Study Stopped
administrative reason
Antipsychotic Discontinuation in High-risk Subjects
1 other identifier
observational
N/A
1 country
1
Brief Summary
- Would be there any difference in dopamine synthesis between remitted clinical high risk subjects for psychosis and healthy control?
- What would happen to dopamine synthesis after antipsychotic discontinuation in clinical high risk subjects for psychosis?
- What about the dopamine synthesis in recurred clinical high risk subjects for psychosis after the discontinuation?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
December 27, 2012
CompletedFirst Posted
Study publicly available on registry
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedOctober 13, 2016
October 1, 2016
3.8 years
December 27, 2012
October 12, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Presynaptic dopamine synthesis in the striatum
measured with \[18F\]DOPA positron emission tomography
baseline
Study Arms (2)
Controls
Healthy control
patients
clinical high risk subjects for psychosis
Eligibility Criteria
Clinical high risk subjects for psychosis who have been treated with antipsychotic medication so that reach to the remission.
You may qualify if:
- Diagnosed as a clinical High Risk
- Treated with antipsychotic drugs
- PSP1-5 (from SIPS criteria) \<3 (severity index)for more than 6 months
- Had not experienced a symptomatic relapse in the 6 months
You may not qualify if:
- Significant abnormality in laboratory tests
- History of head trauma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, 110-744, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jun Soo Kwon, MD PhD
Seoul National University College of Medicine
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 27, 2012
First Posted
January 1, 2013
Study Start
December 1, 2012
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
October 13, 2016
Record last verified: 2016-10
Data Sharing
- IPD Sharing
- Will not share